78 related articles for article (PubMed ID: 20193715)
1. Rapid quantification of itraconazole-resistant Aspergillus fumigatus in air.
Vanhee LM; Perman D; Nelis HJ; Coenye T
J Microbiol Methods; 2010 May; 81(2):197-9. PubMed ID: 20193715
[TBL] [Abstract][Full Text] [Related]
2. Sterol composition of itraconazole-resistant and itraconazole-susceptible isolates of Aspergillus fumigatus.
Dannaoui E; Persat F; Borel E; Piens MA; Picot S
Can J Microbiol; 2001 Aug; 47(8):706-10. PubMed ID: 11575496
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma.
Chen J; Li H; Li R; Bu D; Wan Z
J Antimicrob Chemother; 2005 Jan; 55(1):31-7. PubMed ID: 15563516
[TBL] [Abstract][Full Text] [Related]
4. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
Warn PA; Morrissey G; Morrissey J; Denning DW
J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
[TBL] [Abstract][Full Text] [Related]
5. Hydrocortisone, prednisolone and dexamethasone act on Aspergillus fumigatus in vitro susceptibility to itraconazole.
Ramondenc I; Pinel C; Parat S; Ambroise-Thomas P; Grillot R
Microbios; 2001; 104(407):17-26. PubMed ID: 11229654
[TBL] [Abstract][Full Text] [Related]
6. Detection of Aspergillus fumigatus and a mutation that confers reduced susceptibility to itraconazole and posaconazole by real-time PCR and pyrosequencing.
Trama JP; Mordechai E; Adelson ME
J Clin Microbiol; 2005 Feb; 43(2):906-8. PubMed ID: 15695702
[TBL] [Abstract][Full Text] [Related]
7. Antifungal susceptibility of 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples: analysis by site of isolation.
Guinea J; Peláez T; Alcalá L; Ruiz-Serrano MJ; Bouza E
Antimicrob Agents Chemother; 2005 Aug; 49(8):3495-7. PubMed ID: 16048968
[TBL] [Abstract][Full Text] [Related]
8. Rapid method for testing the susceptibility of Aspergillus fumigatus to amphotericin B, itraconazole, voriconazole and posaconazole by assessment of oxygen consumption.
Araujo R; Coutinho I; Espinel-Ingroff A
J Antimicrob Chemother; 2008 Dec; 62(6):1277-80. PubMed ID: 18824456
[TBL] [Abstract][Full Text] [Related]
9. Correlation between the E test and the CLSI M-38 A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
Guinea J; Peláez T; Alcalá L; Bouza E
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):273-6. PubMed ID: 17141455
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility to five antifungals of Aspergillus fumigatus strains isolated from chronically colonised cystic fibrosis patients receiving azole therapy.
Amorim A; Guedes-Vaz L; Araujo R
Int J Antimicrob Agents; 2010 Apr; 35(4):396-9. PubMed ID: 20138740
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.
Guinea J; Peláez T; Alcalá L; Bouza E
Diagn Microbiol Infect Dis; 2006 Sep; 56(1):53-5. PubMed ID: 16650953
[TBL] [Abstract][Full Text] [Related]
12. Generic substitution of itraconazole resulting in sub-therapeutic levels and resistance.
Pasqualotto AC; Denning DW
Int J Antimicrob Agents; 2007 Jul; 30(1):93-4. PubMed ID: 17412566
[No Abstract] [Full Text] [Related]
13. Multidrug resistance in Aspergillus fumigatus.
Warris A; Weemaes CM; Verweij PE
N Engl J Med; 2002 Dec; 347(26):2173-4. PubMed ID: 12501236
[No Abstract] [Full Text] [Related]
14. In vitro evolution of itraconazole resistance in Aspergillus fumigatus involves multiple mechanisms of resistance.
da Silva Ferreira ME; Capellaro JL; dos Reis Marques E; Malavazi I; Perlin D; Park S; Anderson JB; Colombo AL; Arthington-Skaggs BA; Goldman MH; Goldman GH
Antimicrob Agents Chemother; 2004 Nov; 48(11):4405-13. PubMed ID: 15504870
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
Kaya AD; Kiraz N
Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
[TBL] [Abstract][Full Text] [Related]
16. Antifungal susceptibility of Aspergillus fumigatus clinical isolates collected from various areas in Japan.
Kikuchi K; Watanabe A; Ito J; Oku Y; Wuren T; Taguchi H; Yarita K; Muraosa Y; Yahiro M; Yaguchi T; Kamei K
J Infect Chemother; 2014 May; 20(5):336-8. PubMed ID: 24751235
[TBL] [Abstract][Full Text] [Related]
17. The concentration-dependent nature of in vitro amphotericin B-itraconazole interaction against Aspergillus fumigatus: isobolographic and response surface analysis of complex pharmacodynamic interactions.
Meletiadis J; te Dorsthorst DT; Verweij PE
Int J Antimicrob Agents; 2006 Nov; 28(5):439-49. PubMed ID: 17055706
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.
Martín-Mazuelos E; Pemán J; Valverde A; Chaves M; Serrano MC; Cantón E
J Antimicrob Chemother; 2003 Sep; 52(3):365-70. PubMed ID: 12917236
[TBL] [Abstract][Full Text] [Related]
19. Azole-resistance in Aspergillus: proposed nomenclature and breakpoints.
Verweij PE; Howard SJ; Melchers WJ; Denning DW
Drug Resist Updat; 2009 Dec; 12(6):141-7. PubMed ID: 19879181
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
